BBC - Virtus Biotech Clinical Trials ETF
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
As of Oct 13, 2026: spot at $41.05, ATM IV 470.2%, max pain $45.00, net GEX $738.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $38.6M
- Beta
- 1.31
- 52-Week Range
- 28.725-56.18
- Dividend Yield
- $0.66
- IPO Date
- Dec 17, 2014
- Exchange
- AMEX
What BBC Looks Like to Options Traders Today
IV rank of 94.9% signals elevated pricing relative to the 1-year history, conditions that typically favor premium-selling structures (credit spreads, iron condors, covered calls); positive net gamma exposure ($738) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.132) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The BBC overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
BBC fund facts: expense ratio 0.65%, assets under management $41.1M, NAV $43.27 as of the data source's update on Oct 8, 2026, 130 holdings in its latest file, launched Dec 16, 2014, issued by Virtus. See the BBC holdings.
Frequently asked BBC overview questions
- What is BBC?
- BBC is the ticker symbol for Virtus Biotech Clinical Trials ETF, an listed exchange-traded fund. This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. Listed on AMEX. BBC is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the BBC options snapshot look like today?
- As of Oct 13, 2026, the BBC options snapshot shows spot at $41.05, ATM IV 470.2%, IV rank 94.9%, max pain $45.00, net GEX $738, expected move 134.80%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are BBC's key statistics?
- Virtus Biotech Clinical Trials ETF (BBC) carries a market capitalization of $38.6M, 52-week range of 28.725-56.18. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does BBC belong to?
- Virtus Biotech Clinical Trials ETF operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare BBC's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the BBC data on this page?
- The options snapshot above is dated Oct 13, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.